Access Vascular, Inc. is a Billerica, Massachusetts medical device manufacturer that designs and builds vascular access catheters from a proprietary hydrophilic biomaterial engineered to retain water and mimic the chemistry of the body, with the goal of reducing thrombosis, infection and phlebitis in intravenous therapy. Its FDA-cleared products include HydroPICC, a peripherally inserted central catheter cleared in 2018 and later extended to a dual-lumen configuration, and HydroMID, a midline catheter cleared in 2021, both carrying an anti-thrombogenic indication. The company is a device manufacturer rather than a software or platform business, and publishes no developer program, public API, or machine-readable API contract on any host it operates.
Access Vascular, Inc. is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Vascular Access, and Catheters.
Access Vascular, Inc.’s developer surface includes engineering blog and 10 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: accessvascular
name: Access Vascular, Inc.
description: Access Vascular, Inc. is a Billerica, Massachusetts medical device manufacturer that designs and builds vascular
access catheters from a proprietary hydrophilic biomaterial engineered to retain water and mimic the chemistry of the body,
with the goal of reducing thrombosis, infection and phlebitis in intravenous therapy. Its FDA-cleared products include HydroPICC,
a peripherally inserted central catheter cleared in 2018 and later extended to a dual-lumen configuration, and HydroMID,
a midline catheter cleared in 2021, both carrying an anti-thrombogenic indication. The company is a device manufacturer
rather than a software or platform business, and publishes no developer program, public API, or machine-readable API contract
on any host it operates.
url: https://raw.githubusercontent.com/api-evangelist/accessvascular/refs/heads/main/apis.yml
image: http://static1.squarespace.com/static/6221f3828dc3c91f338d47ed/t/65bacd55b532e27a3ad54ad9/1706741077575/AV_logo_white.png?format=1500w
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Medical Devices
- Healthcare
- Vascular Access
- Catheters
- Biomaterials
- Manufacturing
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://www.accessvascularinc.com/
- type: Blog
url: https://www.accessvascularinc.com/take-action
- type: BlogRSS
url: https://www.accessvascularinc.com/take-action?format=rss
- type: Newsroom
url: https://www.accessvascularinc.com/news
- type: PrivacyPolicy
url: https://www.accessvascularinc.com/privacy-policy
- type: TermsOfService
url: https://www.accessvascularinc.com/terms-and-conditions
- type: About
url: https://www.accessvascularinc.com/company
- type: Careers
url: https://www.accessvascularinc.com/careers
- type: LinkedIn
url: https://www.linkedin.com/company/access-vascular-inc-/
- type: SecondaryMarket
url: https://equityzen.com/company/accessvascular
- type: DomainSecurity
url: security/accessvascular-domain-security.yml
x-enrichment:
date: '2026-09-06'
status: minimal
artifacts_added: 2
pass: local-v3
x-coverage:
state: none
reason: not-a-software-company
detail: Access Vascular, Inc. is a Billerica, Massachusetts catheter manufacturer whose entire public surface is a Squarespace
marketing site about HydroPICC and HydroMID (company, products, news, take-action, careers, IFU pages), with no developer,
docs, portal or integration link anywhere in the nav, footer or sitemap; every REST/GraphQL/MCP/agent-card, /llms.txt
and /.well-known/ path probed on both www.accessvascularinc.com and accessvascularinc.com returns a hard 404 (verified
against a random control path returning the identical 153,854-byte 404 body), and api./docs./developer./portal./app.accessvascularinc.com
do not resolve in DNS at all. The accessvascular.com domain in the harvest lead is unrelated — it is parked for sale at
$4,950 on Spaceship.com and is not operated by this company.
evidence:
- url: https://www.accessvascularinc.com/
status: 200
- url: https://www.accessvascularinc.com/openapi.json
status: 404
- url: https://www.accessvascularinc.com/swagger.json
status: 404
- url: https://www.accessvascularinc.com/api-docs
status: 404
- url: https://www.accessvascularinc.com/graphql
status: 404
- url: https://www.accessvascularinc.com/llms.txt
status: 404
- url: https://www.accessvascularinc.com/developers
status: 404
- url: https://www.accessvascularinc.com/.well-known/agent-card.json
status: 404
- url: https://www.accessvascularinc.com/.well-known/agent.json
status: 404
- url: https://www.accessvascularinc.com/.well-known/api-catalog
status: 404
- url: https://accessvascularinc.com/.well-known/security.txt
status: 404
- url: https://www.accessvascularinc.com/zz-api-evangelist-control-9f3a
status: 404
checked: '2026-09-06'